BlackRock’s Surface Oncology, Inc. Common Stock SURF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-520,886
| Closed | -$453K | – | 5577 |
|
|
2023
Q2 | $453K | Sell |
520,886
-170,192
| -25% | -$121K | ﹤0.01% | 4508 |
|
|
2023
Q1 | $483K | Buy |
691,078
+13,673
| +2% | +$11.1K | ﹤0.01% | 4537 |
|
|
2022
Q4 | $555K | Sell |
677,405
-349,302
| -34% | -$344K | ﹤0.01% | 4580 |
|
|
2022
Q3 | $1.07M | Sell |
1,026,707
-6,323
| -0.6% | -$10.1K | ﹤0.01% | 4456 |
|
|
2022
Q2 | $1.69M | Sell |
1,033,030
-1,515,075
| -59% | -$3.15M | ﹤0.01% | 4319 |
|
|
2022
Q1 | $7.49M | Sell |
2,548,105
-14,580
| -0.6% | -$51.1K | ﹤0.01% | 3734 |
|
|
2021
Q4 | $12.3M | Buy |
2,562,685
+137,742
| +6% | +$889K | ﹤0.01% | 3553 |
|
|
2021
Q3 | $18.4M | Sell |
2,424,943
-119,990
| -5% | -$768K | ﹤0.01% | 3336 |
|
|
2021
Q2 | $19M | Buy |
2,544,933
+1,580,573
| +164% | +$12.2M | ﹤0.01% | 3335 |
|
|
2021
Q1 | $7.52M | Buy |
964,360
+12,483
| +1% | +$125K | ﹤0.01% | 3738 |
|
|
2020
Q4 | $8.8M | Buy |
951,877
+661,807
| +228% | +$5.75M | ﹤0.01% | 3432 |
|
|
2020
Q3 | $2M | Buy |
290,070
+60,308
| +26% | +$366K | ﹤0.01% | 3898 |
|
|
2020
Q2 | $1.51M | Buy |
229,762
+20,497
| +10% | +$74K | ﹤0.01% | 3911 |
|
|
2020
Q1 | $392K | Sell |
209,265
-37,985
| -15% | -$100K | ﹤0.01% | 4101 |
|
|
2019
Q4 | $465K | Sell |
247,250
-312,374
| -56% | -$520K | ﹤0.01% | 4174 |
|
|
2019
Q3 | $795K | Sell |
559,624
-15,812
| -3% | -$34.5K | ﹤0.01% | 4054 |
|
|
2019
Q2 | $1.62M | Sell |
575,436
-493,312
| -46% | -$1.96M | ﹤0.01% | 3847 |
|
|
2019
Q1 | $5.1M | Sell |
1,068,748
-28,293
| -3% | -$139K | ﹤0.01% | 3402 |
|
|
2018
Q4 | $4.65M | Buy |
1,097,041
+496,072
| +83% | +$3.83M | ﹤0.01% | 3413 |
|
|
2018
Q3 | $6.57M | Sell |
600,969
-26,279
| -4% | -$308K | ﹤0.01% | 3411 |
|
|
2018
Q2 | $10.2M | Buy |
+627,248
| New | +$9.08M | ﹤0.01% | 3225 |
|
BlackRock's SURF Position: Q3 2023 in Review
BlackRock sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2023, closing a stake of 520,886 shares — an estimated $453K sold.
BlackRock first reported a position in SURF in Q2 2018 and held it in 21 quarters. The position peaked at $19M in Q2 2021. 0 funds tracked by Wall St. Rank hold SURF as of Q3 2023.
- BlackRock reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- BlackRock sold 520,886 Surface Oncology, Inc. Common Stock shares in Q3 2023, an estimated $453K.
- BlackRock first reported a position in Surface Oncology, Inc. Common Stock in Q2 2018 and held it in 21 quarters.
- BlackRock's Surface Oncology, Inc. Common Stock position peaked at $19M in Q2 2021.
- 0 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2023.
Based on BlackRock's 13F filing for Q3 2023, filed 13 Nov 2023.